In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency
- PMID: 7489410
- DOI: 10.1038/nm1295-1284
In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency
Abstract
Although it is presumed that the integration of HIV-1 into the genome of infected CD4+ T lymphocytes allows viral persistence, there has been little direct evidence that CD4+ T cells with integrated provirus function as a latent reservoir for HIV-1 in infected individuals. Using resting CD4+ T-cell populations of extremely high purity and a novel assay that selectively and unambiguously detects integrated HIV-1, we show that resting CD4+ T cells harbouring integrated provirus are present in some infected individuals. However, these cells do not accumulate within the circulating pool of resting CD4+ T cells in the early stages of HIV-1 infection and do not accumulate even after prolonged periods in long-term survivors of HIV-1 infection. These results suggest that because of viral cytopathic effects and/or host effector mechanisms, productively infected CD4+ T cells do not generally survive for long enough to revert to a resting memory state in vivo.
Similar articles
-
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.J Virol. 2003 Jul;77(13):7383-92. doi: 10.1128/jvi.77.13.7383-7392.2003. J Virol. 2003. PMID: 12805437 Free PMC article.
-
The role of integration and clonal expansion in HIV infection: live long and prosper.Retrovirology. 2018 Oct 23;15(1):71. doi: 10.1186/s12977-018-0448-8. Retrovirology. 2018. PMID: 30352600 Free PMC article. Review.
-
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.Nature. 2017 Mar 23;543(7646):564-567. doi: 10.1038/nature21710. Epub 2017 Mar 15. Nature. 2017. PMID: 28297712
-
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature. 1997 May 8;387(6629):183-8. doi: 10.1038/387183a0. Nature. 1997. PMID: 9144289
-
Experimental approaches to the study of HIV-1 latency.Nat Rev Microbiol. 2007 Feb;5(2):95-106. doi: 10.1038/nrmicro1580. Nat Rev Microbiol. 2007. PMID: 17224919 Review.
Cited by
-
Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4+ T cells: A pooled data-analysis.Front Immunol. 2022 Aug 26;13:915805. doi: 10.3389/fimmu.2022.915805. eCollection 2022. Front Immunol. 2022. PMID: 36090997 Free PMC article.
-
HIV/AIDS eradication.Bioorg Med Chem Lett. 2013 Jul 15;23(14):4003-10. doi: 10.1016/j.bmcl.2013.05.032. Epub 2013 May 18. Bioorg Med Chem Lett. 2013. PMID: 23735743 Free PMC article. Review.
-
Targeted DNA mutagenesis for the cure of chronic viral infections.J Virol. 2012 Sep;86(17):8920-36. doi: 10.1128/JVI.00052-12. Epub 2012 Jun 20. J Virol. 2012. PMID: 22718830 Free PMC article. Review.
-
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells.Nat Immunol. 2024 Mar;25(3):462-470. doi: 10.1038/s41590-023-01741-5. Epub 2024 Jan 26. Nat Immunol. 2024. PMID: 38278966 Free PMC article.
-
Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):221-228. doi: 10.1097/QAI.0000000000001187. J Acquir Immune Defic Syndr. 2017. PMID: 27683060 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials